Controlled release of enhanced cross-hybrid IgGA Fc PD-L1 inhibitors using oncolytic adenoviruses.

Mol Ther Oncolytics · 2023 · PMC9995465 · PMID 36911070

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

9 With all cell lines, a clear trend can be observed in which Cab FT was more potent at lower concentrations (between 2.5–0.3125 μg/mL) compared with Cab ( Figure 1 A).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.